Video Library
Video Library
World Heart Federation Roadmap
In this video, Prof. Christopher Cannon provides a comprehensive overview of our infographic on the World Heart Foundation’s Cholesterol Roadmap (2022) for the management and prevention of atherosclerotic cardiovascular disease (ASCVD). He discusses various approaches for ASCVD prevention, emphasizes regional differences in adherence to ASCVD treatment guidelines, and highlights barriers to effective risk management. This roadmap offers a scientifically sound foundation for policymakers to implement changes aimed at reducing the burden of ASCVD.
Infographics
Articles
Case Studies
Case Studies
August 2023
Take this short quiz to test your knowledge on the recently published debate on dyslipidemias titled “Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers”.
CLICK HERE TO VIEW THE DEBATE.
Eur Heart J. 2023 Jul 1;44(25):2292-2304. doi: 10.1093/eurheartj/ehad275
Case Studies
Quiz of the month – April 2023
Take our patient case study quiz specially curated for you by our Faculty Member, Prof. Samer Ellahham.
Case Study: A 65-year-old man with a history of dyslipidemia, type 2 diabetes mellitus and systemic hypertension.
Presentation:
New onset crescendo angina x 5 days culminating
Rest pain for the past 2h
No history of other vascular events or heart attack, no TIA or stroke
Weight: 90 kg
Exam: BP 150/85 (slightly elevated), Heart Rate 80
No murmur detected
Medication:
Valsartan 160 mg daily, Aspirin 81 mg daily, Rosuvastatin 10 mg daily, Metformin 500 mg twice daily
Labs:
BMI 31kg/m2, waist circumference 101.6 cm (40 inches), (-) tobacco (quit last year – 60-pack-year history)
Normal CBC, electrolytes
Troponin: Elevated
Electrocardiogram:1-2 mm horizontal ST depression infero-lateral leads
Chest X-ray: Normal
Lipid panel:
Total cholesterol (TC) 192 mg/dL
HDL-C 46 mg/dL
Triglycerides 180 mg/dL (non-fasting)
LDL-C 110 mg/dL
Non-HDL-C 146 mg/ dL
What are the first impressions about this patient?